SMS Messaging for Invitation in the Cervical Cancer Screening Programme
CERCA-SMS
2 other identifiers
interventional
450
1 country
1
Brief Summary
A study on two different methods of invitation to participate to the cervical cancer screening programme will be conducted within a demonstration project to switch from cytology-based screening to HPV-based screening using self-sampling delivered through the network of pharmacy offices among regular screening attendants in the Barcelona Metropolitana Sud Area, in Catalonia. At the moment, eligible women are invited to participate to cervical cancer screening via a telephone call invitation explaining the new self-sampling method. Invitation via SMS containing a link to a webpage with information on most frequent questions might be an adequate alternative method that would save costs and workload on human resources. The aim of this study is to assess the impact on cervical cancer screening participation of an invitation method based on text messaging (SMS). The invitation method will be evaluated through an interventional trial, in which we will compare the invitation to cervical cancer screening using SMS versus a telephone call invitation explaining the new self-sampling method.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 8, 2021
CompletedFirst Submitted
Initial submission to the registry
May 2, 2022
CompletedFirst Posted
Study publicly available on registry
May 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedMay 5, 2022
May 1, 2022
7 months
May 2, 2022
May 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Participation in cervical cancer screening program
Participation (no/yes) in cervical cancer screening program will be gathered prospectively 12 weeks after sending the screening invitation (day 0).
12 weeks
Study Arms (2)
Experimental - Intervention
EXPERIMENTALSMS invitation to participate in cervical cancer screening using HPV self-sampling.
Active Comparator - Usual Care
ACTIVE COMPARATORPhone call invitation to participate in cervical cancer screening using HPV self-sampling.
Interventions
Behavioral: SMS to invite to cervical cancer screening using HPV self-sampling.
Behavioral: Phone call to invite to cervical cancer screening using HPV self-sampling.
Eligibility Criteria
You may qualify if:
- Eligible women for cervical cancer screening aged 30 to 65 years of age.
- Registered at the Health Care Database (RCA).
You may not qualify if:
- Individuals without a mobile phone number registered at the RCA.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institut Català d'Oncologia
L'Hospitalet de Llobregat, Catalunya, Spain, 08908, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paula Peremiquel-Trillas, MD, MPH, PhDc
Institut Català d'Oncologia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2022
First Posted
May 5, 2022
Study Start
November 8, 2021
Primary Completion
May 31, 2022
Study Completion
December 31, 2022
Last Updated
May 5, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share